Literature DB >> 10537327

Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance.

R B Diasio, M R Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10537327

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  22 in total

Review 1.  Pharmacogenetics in the management of breast cancer -- prospects for individualised treatment.

Authors:  Fiona H Blackhall; Sacha Howell; Bill Newman
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 2.  Thymidine Phosphorylase in Cancer; Enemy or Friend?

Authors:  Yasir Y Elamin; Shereen Rafee; Nemer Osman; Kenneth J O Byrne; Kathy Gately
Journal:  Cancer Microenviron       Date:  2015-08-23

3.  Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression.

Authors:  Osamu Kikuchi; Shinya Ohashi; Yukie Nakai; Shunsaku Nakagawa; Kazuaki Matsuoka; Takashi Kobunai; Teiji Takechi; Yusuke Amanuma; Masahiro Yoshioka; Tomomi Ida; Yoshihiro Yamamoto; Yasushi Okuno; Shin'ichi Miyamoto; Hiroshi Nakagawa; Kazuo Matsubara; Tsutomu Chiba; Manabu Muto
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

4.  A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy.

Authors:  Jai N Patel; Bert H O'Neil; Allison M Deal; Joseph G Ibrahim; Gary B Sherrill; Oludamilola A Olajide; Prashanti M Atluri; John J Inzerillo; Christopher H Chay; Howard L McLeod; Christine M Walko
Journal:  Oncologist       Date:  2014-08-12

5.  Evaluation of the 5-fluorouracil plasma level in patients with colorectal cancer undergoing continuous infusion chemotherapy.

Authors:  Yu Abe; Naoki Sakuyama; Tsuyoshi Sato; Kenji Kishine; Kiichi Nagayasu; Akinori Nakatani; Masayuki Kitajima; Tomoo Watanabe; Kazuhiko Nishimura; Takumi Ochiai; Isao Nagaoka
Journal:  Mol Clin Oncol       Date:  2019-07-03

6.  Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer.

Authors:  Marko Kornmann; Karl H Link; Inga Galuba; Kati Ott; Wolfgang Schwabe; Peter Häusler; Peter Scholz; Jörn Sträter; Sucan Polat; Bernhard Leibl; Erika Kettner; Christoph Schlichting; Wolfram Baumann; Harald Schramm; Ute Hecker; Karsten Ridwelski; Jürgen H Vogt; Klaus-Ullrich Zerbian; Frank Schütze; Ernst D Kreuser; Detlev Behnke; Hans G Beger
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

Review 7.  Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?

Authors:  Barry Iacopetta; Kazuyuki Kawakami; Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

8.  Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients.

Authors:  Jun Han; Long-Fei Rong; Chuan-Bin Shi; Xiao-Gang Dong; Jie Wang; Bao-Lin Wang; Hao Wen; Zhen-Yu He
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

9.  The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer.

Authors:  Grant R Williams; Allison M Deal; Shlomit Strulov Shachar; Christine M Walko; Jai N Patel; Bert O'Neil; Howard L McLeod; Marc S Weinberg; Seul Ki Choi; Hyman B Muss; Hanna K Sanoff
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-20       Impact factor: 3.333

10.  Gastric cancer: Classification, histology and application of molecular pathology.

Authors:  Bing Hu; Nassim El Hajj; Scott Sittler; Nancy Lammert; Robert Barnes; Aurelia Meloni-Ehrig
Journal:  J Gastrointest Oncol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.